Proponents of ivermectin for COVID-19 have long been talking about an expected review and meta-analysis led by Andrew Hill, PhD, of the University of Liverpool.
These results were finally published this week in Open Forum Infectious Diseases, and they’re positive — but they haven’t escaped criticism, and most researchers still want results from a randomized controlled trial.
The review and meta-analysis was conducted as part of the International Ivermectin Project Team from December 2020 to May 2021. Ivermectin proponents said Hill was conducting the analysis for the WHO, but MedPage Today was not able to confirm WHO involvement. Hill did not respond to an email request for comment.
READ FULL ARTICLE HERE > https://www.medpagetoday.com/special-reports/exclusives/93485